Home › Down Syndrome › North Carolina › Durham
Down Syndrome clinical trials in Durham, NC
6 studies for Down Syndrome are looking for participants at sites in and around Durham (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RecruitingPhase 2
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi away
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
RecruitingObservational study
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi away
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
RecruitingObservational studyHealthy volunteers welcome
- Duke University Health System, Durham
Collaboration for Down Syndrome Progress (CDP)
RecruitingObservational study
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi away
Physical Activity and Community EmPOWERment Project
RecruitingHealthy volunteers welcome
- University of North Carolina, Chapel Hill · 10 mi away
Retinal Imaging in Neurodegenerative Disease
RecruitingObservational studyHealthy volunteers welcome
- Duke University Medical Center, Durham
About Down Syndrome
About 1 in 700 babies are born with the birth defect known as Down Syndrome. Learn about the different Down Syndrome types and related health issues.
More about Down Syndrome on MedlinePlus
Down Syndrome trials in other cities
- Aurora, CO7 studies
- Houston, TX6 studies
- Phoenix, AZ6 studies
- Nashville, TN5 studies
- Cincinnati, OH5 studies
- Cleveland, OH5 studies
- Kansas City, KS5 studies
- Philadelphia, PA5 studies
- Ann Arbor, MI5 studies
- Orlando, FL5 studies
- Birmingham, AL4 studies
- San Diego, CA4 studies
Other studies in Durham
- Breast Cancer63 studies
- Cancer (all types)59 studies
- Non-Small Cell Lung Cancer39 studies
- Multiple Myeloma37 studies
- Acute Myeloid Leukemia33 studies
- Metastatic Cancer33 studies
- Lung Cancer32 studies
- Prostate Cancer32 studies
- Colorectal Cancer28 studies
- Chronic Lymphocytic Leukemia27 studies
- Ovarian Cancer27 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.